BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18811697)

  • 1. Identification of a previously unrecognized microdeletion syndrome of 16q11.2q12.2.
    Ballif BC; Theisen A; McDonald-McGinn DM; Zackai EH; Hersh JH; Bejjani BA; Shaffer LG
    Clin Genet; 2008 Nov; 74(5):469-75. PubMed ID: 18811697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
    Battaglia A; Hoyme HE; Dallapiccola B; Zackai E; Hudgins L; McDonald-McGinn D; Bahi-Buisson N; Romano C; Williams CA; Brailey LL; Zuberi SM; Carey JC
    Pediatrics; 2008 Feb; 121(2):404-10. PubMed ID: 18245432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
    Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
    J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2.
    Ballif BC; Hornor SA; Jenkins E; Madan-Khetarpal S; Surti U; Jackson KE; Asamoah A; Brock PL; Gowans GC; Conway RL; Graham JM; Medne L; Zackai EH; Shaikh TH; Geoghegan J; Selzer RR; Eis PS; Bejjani BA; Shaffer LG
    Nat Genet; 2007 Sep; 39(9):1071-3. PubMed ID: 17704777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17p11.2p12 triplication and del(17)q11.2q12 in a severely affected child with dup(17)p11.2p12 syndrome.
    Girirajan S; Williams S; Garbern J; Nowak N; Hatchwell E; Elsea S
    Clin Genet; 2007 Jul; 72(1):47-58. PubMed ID: 17594399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 19q13.11 deletion syndrome: a novel clinically recognisable genetic condition identified by array comparative genomic hybridisation.
    Malan V; Raoul O; Firth HV; Royer G; Turleau C; Bernheim A; Willatt L; Munnich A; Vekemans M; Lyonnet S; Cormier-Daire V; Colleaux L
    J Med Genet; 2009 Sep; 46(9):635-40. PubMed ID: 19126570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New cases and refinement of the critical region in the 1q41q42 microdeletion syndrome.
    Rosenfeld JA; Lacassie Y; El-Khechen D; Escobar LF; Reggin J; Heuer C; Chen E; Jenkins LS; Collins AT; Zinner S; Babcock M; Morrow B; Schultz RA; Torchia BS; Ballif BC; Tsuchiya KD; Shaffer LG
    Eur J Med Genet; 2011; 54(1):42-9. PubMed ID: 20951845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximal interstitial 1p36 deletion syndrome: the most proximal 3.5-Mb microdeletion identified on a dysmorphic and mentally retarded patient with inv(3)(p14.1q26.2).
    Shimojima K; Páez MT; Kurosawa K; Yamamoto T
    Brain Dev; 2009 Sep; 31(8):629-33. PubMed ID: 18835671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1.
    Rajcan-Separovic E; Harvard C; Liu X; McGillivray B; Hall JG; Qiao Y; Hurlburt J; Hildebrand J; Mickelson EC; Holden JJ; Lewis ME
    J Med Genet; 2007 Apr; 44(4):269-76. PubMed ID: 16963482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrome.
    Kurosawa K; Kawame H; Okamoto N; Ochiai Y; Akatsuka A; Kobayashi M; Shimohira M; Mizuno S; Wada K; Fukushima Y; Kawawaki H; Yamamoto T; Masuno M; Imaizumi K; Kuroki Y
    Brain Dev; 2005 Aug; 27(5):378-82. PubMed ID: 16023556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a natural panel of 11p11.2 deletions and further delineation of the critical region involved in Potocki-Shaffer syndrome.
    Wakui K; Gregato G; Ballif BC; Glotzbach CD; Bailey KA; Kuo PL; Sue WC; Sheffield LJ; Irons M; Gomez EG; Hecht JT; Potocki L; Shaffer LG
    Eur J Hum Genet; 2005 May; 13(5):528-40. PubMed ID: 15852040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome.
    Tan TY; Aftimos S; Worgan L; Susman R; Wilson M; Ghedia S; Kirk EP; Love D; Ronan A; Darmanian A; Slavotinek A; Hogue J; Moeschler JB; Ozmore J; Widmer R; Bruno D; Savarirayan R; Peters G
    J Med Genet; 2009 Jul; 46(7):480-9. PubMed ID: 19447831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset myoclonic epilepsy and 15q26 microdeletion: observation of the first case.
    Veredice C; Bianco F; Contaldo I; Orteschi D; Stefanini MC; Battaglia D; Lettori D; Guzzetta F; Zollino M
    Epilepsia; 2009 Jul; 50(7):1810-5. PubMed ID: 19486360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microdeletion syndromes].
    Seemanová E
    Cas Lek Cesk; 2002 Jun; 141(12):363-70. PubMed ID: 12238021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent 16p11.2 microdeletions in autism.
    Kumar RA; KaraMohamed S; Sudi J; Conrad DF; Brune C; Badner JA; Gilliam TC; Nowak NJ; Cook EH; Dobyns WB; Christian SL
    Hum Mol Genet; 2008 Feb; 17(4):628-38. PubMed ID: 18156158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Del 1p36 syndrome: a newly emerging clinical entity.
    Battaglia A
    Brain Dev; 2005 Aug; 27(5):358-61. PubMed ID: 16023552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case series: 2q33.1 microdeletion syndrome--further delineation of the phenotype.
    Balasubramanian M; Smith K; Basel-Vanagaite L; Feingold MF; Brock P; Gowans GC; Vasudevan PC; Cresswell L; Taylor EJ; Harris CJ; Friedman N; Moran R; Feret H; Zackai EH; Theisen A; Rosenfeld JA; Parker MJ
    J Med Genet; 2011 May; 48(5):290-8. PubMed ID: 21343628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome.
    Van der Aa N; Rooms L; Vandeweyer G; van den Ende J; Reyniers E; Fichera M; Romano C; Delle Chiaie B; Mortier G; Menten B; Destrée A; Maystadt I; Männik K; Kurg A; Reimand T; McMullan D; Oley C; Brueton L; Bongers EM; van Bon BW; Pfund R; Jacquemont S; Ferrarini A; Martinet D; Schrander-Stumpel C; Stegmann AP; Frints SG; de Vries BB; Ceulemans B; Kooy RF
    Eur J Med Genet; 2009; 52(2-3):94-100. PubMed ID: 19249392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiling path resolution mapping of constitutional 1p36 deletions by array-CGH: contiguous gene deletion or "deletion with positional effect" syndrome?
    Redon R; Rio M; Gregory SG; Cooper RA; Fiegler H; Sanlaville D; Banerjee R; Scott C; Carr P; Langford C; Cormier-Daire V; Munnich A; Carter NP; Colleaux L
    J Med Genet; 2005 Feb; 42(2):166-71. PubMed ID: 15689456
    [No Abstract]   [Full Text] [Related]  

  • 20. A newly recognised microdeletion syndrome of 2p15-16.1 manifesting moderate developmental delay, autistic behaviour, short stature, microcephaly, and dysmorphic features: a new patient with 3.2 Mb deletion.
    Liang JS; Shimojima K; Ohno K; Sugiura C; Une Y; Ohno K; Yamamoto T
    J Med Genet; 2009 Sep; 46(9):645-7. PubMed ID: 19724011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.